MEDICAPQPharmaceuticals
Medi Caps Ltd — Profit & Loss Statement
₹23.20
-3.17%
Medi Caps Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.21 Cr | 6795.03 | — |
| Tax Rate For Calcs | 0.32 | 0.30 | 0.30 | 0.00 | — |
| Normalized EBITDA | 0.90 Cr | 0.44 Cr | 6.02 Cr | 11.50 Cr | — |
| Total Unusual Items | 0.00 | 0.00 | 0.71 Cr | 0.47 Cr | — |
| Total Unusual Items Excluding Goodwill | 0.00 | 0.00 | 0.71 Cr | 0.47 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | -0.57 Cr | -2.24 Cr | 1.87 Cr | 10.04 Cr | — |
| Reconciled Depreciation | 1.72 Cr | 1.69 Cr | 1.81 Cr | 1.90 Cr | — |
| Reconciled Cost Of Revenue | 10.65 Cr | 9.52 Cr | 25.11 Cr | 33.45 Cr | — |
| EBITDA | 0.90 Cr | 0.44 Cr | 6.73 Cr | 11.97 Cr | — |
| EBIT | -0.82 Cr | -1.25 Cr | 4.92 Cr | 10.07 Cr | — |
| Net Interest Income | -0.02 Cr | 0.00 | 0.49 Cr | 0.42 Cr | — |
| Interest Expense | 0.02 Cr | 0.00 | 16000.00 | 97000.00 | — |
| Normalized Income | -0.57 Cr | -2.24 Cr | 1.37 Cr | 9.57 Cr | — |
| Net Income From Continuing And Discontinued Operation | -0.57 Cr | -2.24 Cr | 1.76 Cr | 10.08 Cr | — |
| Total Expenses | 28.92 Cr | 28.28 Cr | 45.76 Cr | 60.06 Cr | — |
| Diluted Average Shares | 1.24 Cr | 1.24 Cr | 1.25 Cr | 1.25 Cr | — |
| Basic Average Shares | 1.24 Cr | 1.24 Cr | 1.25 Cr | 1.25 Cr | — |
| Diluted EPS | -0.46 | -1.80 | 1.41 | 8.08 | — |
| Basic EPS | -0.46 | -1.80 | 1.41 | 8.08 | — |
| Diluted NI Availto Com Stockholders | -0.57 Cr | -2.24 Cr | 1.76 Cr | 10.08 Cr | — |
| Net Income Common Stockholders | -0.57 Cr | -2.24 Cr | 1.76 Cr | 10.08 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | -0.57 Cr | -2.24 Cr | 1.76 Cr | 10.08 Cr | — |
| Minority Interests | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income Including Noncontrolling Interests | -0.57 Cr | -2.24 Cr | 1.76 Cr | 10.08 Cr | — |
| Net Income Extraordinary | 0.00 | 0.00 | 0.00 | — | — |
| Net Income Discontinuous Operations | 0.00 | 0.00 | -0.11 Cr | 0.04 Cr | — |
| Net Income Continuous Operations | -0.57 Cr | -2.24 Cr | 1.87 Cr | 10.04 Cr | — |
| Tax Provision | -0.27 Cr | 0.99 Cr | 3.05 Cr | 0.01 Cr | — |
| Pretax Income | -0.84 Cr | -1.25 Cr | 4.92 Cr | 10.06 Cr | — |
| Other Non Operating Income Expenses | 2.73 Cr | 0.47 Cr | 0.05 Cr | 0.05 Cr | — |
| Special Income Charges | 0.00 | 0.00 | 0.00 | 0.05 Cr | — |
| Net Non Operating Interest Income Expense | -0.02 Cr | 0.00 | 0.49 Cr | 0.42 Cr | — |
| Interest Expense Non Operating | 0.02 Cr | 0.00 | 16000.00 | 97000.00 | — |
| Operating Income | -3.55 Cr | -1.72 Cr | 2.81 Cr | 8.25 Cr | — |
| Operating Expense | 18.27 Cr | 18.77 Cr | 20.65 Cr | 26.61 Cr | — |
| Other Operating Expenses | 7.70 Cr | 9.26 Cr | 5.11 Cr | 5.21 Cr | — |
| Depreciation And Amortization In Income Statement | 1.72 Cr | 1.69 Cr | 1.74 Cr | 1.81 Cr | — |
| Depreciation Income Statement | 1.72 Cr | 1.69 Cr | 1.74 Cr | 1.81 Cr | — |
| Selling General And Administration | 1.37 Cr | 1.54 Cr | 6.17 Cr | 13.37 Cr | — |
| Selling And Marketing Expense | 1.37 Cr | 1.54 Cr | 5.69 Cr | 13.02 Cr | — |
| Gross Profit | 14.72 Cr | 17.05 Cr | 23.47 Cr | 34.86 Cr | — |
| Cost Of Revenue | 10.65 Cr | 9.52 Cr | 25.11 Cr | 33.45 Cr | — |
| Total Revenue | 25.37 Cr | 26.56 Cr | 48.58 Cr | 68.31 Cr | — |
| Operating Revenue | 25.37 Cr | 26.56 Cr | 48.58 Cr | 68.31 Cr | — |
| Interest Income | — | 0.53 Cr | 0.62 Cr | 0.53 Cr | 0.34 Cr |
| Rent Expense Supplemental | — | 0.05 Cr | 0.03 Cr | 0.03 Cr | 0.02 Cr |
| Total Other Finance Cost | — | 0.04 Cr | 0.13 Cr | 0.10 Cr | 0.10 Cr |
| Interest Income Non Operating | — | 0.53 Cr | 0.62 Cr | 0.53 Cr | 0.34 Cr |
| Research And Development | — | 0.03 Cr | 0.03 Cr | 0.03 Cr | 0.03 Cr |
| General And Administrative Expense | — | 2.27 Cr | 0.48 Cr | 0.35 Cr | 0.45 Cr |
| Rent And Landing Fees | — | 0.05 Cr | 0.03 Cr | 0.03 Cr | 0.02 Cr |
| Other Special Charges | — | — | — | -0.05 Cr | — |
| Write Off | — | — | — | 0.00 | 0.03 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Medi Caps Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.